NCT01797484View on ClinicalTrials.gov

Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Coronary Artery DiseaseAcute Myocardial Ischemia
Interventions
DRUG

Ranolazine

Improvement of myocardial microcirculation

Trial Locations (1)

20246

University Heart Center Hamburg Eppendorf, Hamburg

All Listed Sponsors
lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT01797484 - Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia | Biotech Hunter | Biotech Hunter